1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Cystoscopy
        1.2.3 Biopsy
        1.2.4 Intravenous Pyelogram
        1.2.5 CT Scan
        1.2.6 Kidney Ultrasound
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Pharmaceutical Labs
        1.3.4 Genomics Laboratories
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Kidney Cancer Therapeutics and Diagnostics Market Perspective (2017-2028)
    2.2 Kidney Cancer Therapeutics and Diagnostics Growth Trends by Region
        2.2.1 Kidney Cancer Therapeutics and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Kidney Cancer Therapeutics and Diagnostics Market Dynamics
        2.3.1 Kidney Cancer Therapeutics and Diagnostics Industry Trends
        2.3.2 Kidney Cancer Therapeutics and Diagnostics Market Drivers
        2.3.3 Kidney Cancer Therapeutics and Diagnostics Market Challenges
        2.3.4 Kidney Cancer Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Kidney Cancer Therapeutics and Diagnostics Players by Revenue
        3.1.1 Global Top Kidney Cancer Therapeutics and Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Kidney Cancer Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Kidney Cancer Therapeutics and Diagnostics Revenue
    3.4 Global Kidney Cancer Therapeutics and Diagnostics Market Concentration Ratio
        3.4.1 Global Kidney Cancer Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Therapeutics and Diagnostics Revenue in 2021
    3.5 Kidney Cancer Therapeutics and Diagnostics Key Players Head office and Area Served
    3.6 Key Players Kidney Cancer Therapeutics and Diagnostics Product Solution and Service
    3.7 Date of Enter into Kidney Cancer Therapeutics and Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Therapeutics and Diagnostics Breakdown Data by Type
    4.1 Global Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028)
5 Kidney Cancer Therapeutics and Diagnostics Breakdown Data by Application
    5.1 Global Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
    6.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type
        6.2.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
    6.3 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application
        6.3.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
    6.4 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country
        6.4.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
    7.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type
        7.2.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application
        7.3.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country
        7.4.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
    9.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type
        9.2.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application
        9.3.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country
        9.4.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Details
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Kidney Cancer Therapeutics and Diagnostics Introduction
        11.1.4 Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.1.5 Bayer Recent Developments
    11.2 Hoffmann La Roche
        11.2.1 Hoffmann La Roche Company Details
        11.2.2 Hoffmann La Roche Business Overview
        11.2.3 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Introduction
        11.2.4 Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.2.5 Hoffmann La Roche Recent Developments
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Introduction
        11.3.4 GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Kidney Cancer Therapeutics and Diagnostics Introduction
        11.4.4 Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Kidney Cancer Therapeutics and Diagnostics Introduction
        11.5.4 Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.5.5 Pfizer Recent Developments
    11.6 Abbott Laboratories
        11.6.1 Abbott Laboratories Company Details
        11.6.2 Abbott Laboratories Business Overview
        11.6.3 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Introduction
        11.6.4 Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.6.5 Abbott Laboratories Recent Developments
    11.7 Amgen
        11.7.1 Amgen Company Details
        11.7.2 Amgen Business Overview
        11.7.3 Amgen Kidney Cancer Therapeutics and Diagnostics Introduction
        11.7.4 Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.7.5 Amgen Recent Developments
    11.8 Genentech
        11.8.1 Genentech Company Details
        11.8.2 Genentech Business Overview
        11.8.3 Genentech Kidney Cancer Therapeutics and Diagnostics Introduction
        11.8.4 Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.8.5 Genentech Recent Developments
    11.9 Cerulean Pharma
        11.9.1 Cerulean Pharma Company Details
        11.9.2 Cerulean Pharma Business Overview
        11.9.3 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Introduction
        11.9.4 Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.9.5 Cerulean Pharma Recent Developments
    11.10 Seattle Genetics
        11.10.1 Seattle Genetics Company Details
        11.10.2 Seattle Genetics Business Overview
        11.10.3 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Introduction
        11.10.4 Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
        11.10.5 Seattle Genetics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Cystoscopy
    Table 3. Key Players of Biopsy
    Table 4. Key Players of Intravenous Pyelogram
    Table 5. Key Players of CT Scan
    Table 6. Key Players of Kidney Ultrasound
    Table 7. Key Players of Others
    Table 8. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Region (2017-2022)
    Table 12. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Region (2023-2028)
    Table 14. Kidney Cancer Therapeutics and Diagnostics Market Trends
    Table 15. Kidney Cancer Therapeutics and Diagnostics Market Drivers
    Table 16. Kidney Cancer Therapeutics and Diagnostics Market Challenges
    Table 17. Kidney Cancer Therapeutics and Diagnostics Market Restraints
    Table 18. Global Kidney Cancer Therapeutics and Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Players (2017-2022)
    Table 20. Global Top Kidney Cancer Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics and Diagnostics as of 2021)
    Table 21. Ranking of Global Top Kidney Cancer Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Kidney Cancer Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Kidney Cancer Therapeutics and Diagnostics Product Solution and Service
    Table 25. Date of Enter into Kidney Cancer Therapeutics and Diagnostics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2017-2022)
    Table 29. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2023-2028)
    Table 31. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Application (2017-2022)
    Table 33. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Application (2023-2028)
    Table 35. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Bayer Company Details
    Table 66. Bayer Business Overview
    Table 67. Bayer Kidney Cancer Therapeutics and Diagnostics Product
    Table 68. Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 69. Bayer Recent Developments
    Table 70. Hoffmann La Roche Company Details
    Table 71. Hoffmann La Roche Business Overview
    Table 72. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product
    Table 73. Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 74. Hoffmann La Roche Recent Developments
    Table 75. GlaxoSmithKline Company Details
    Table 76. GlaxoSmithKline Business Overview
    Table 77. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product
    Table 78. GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 79. GlaxoSmithKline Recent Developments
    Table 80. Novartis Company Details
    Table 81. Novartis Business Overview
    Table 82. Novartis Kidney Cancer Therapeutics and Diagnostics Product
    Table 83. Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 84. Novartis Recent Developments
    Table 85. Pfizer Company Details
    Table 86. Pfizer Business Overview
    Table 87. Pfizer Kidney Cancer Therapeutics and Diagnostics Product
    Table 88. Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 89. Pfizer Recent Developments
    Table 90. Abbott Laboratories Company Details
    Table 91. Abbott Laboratories Business Overview
    Table 92. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product
    Table 93. Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 94. Abbott Laboratories Recent Developments
    Table 95. Amgen Company Details
    Table 96. Amgen Business Overview
    Table 97. Amgen Kidney Cancer Therapeutics and Diagnostics Product
    Table 98. Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 99. Amgen Recent Developments
    Table 100. Genentech Company Details
    Table 101. Genentech Business Overview
    Table 102. Genentech Kidney Cancer Therapeutics and Diagnostics Product
    Table 103. Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 104. Genentech Recent Developments
    Table 105. Cerulean Pharma Company Details
    Table 106. Cerulean Pharma Business Overview
    Table 107. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product
    Table 108. Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 109. Cerulean Pharma Recent Developments
    Table 110. Seattle Genetics Company Details
    Table 111. Seattle Genetics Business Overview
    Table 112. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product
    Table 113. Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 114. Seattle Genetics Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Cystoscopy Features
    Figure 3. Biopsy Features
    Figure 4. Intravenous Pyelogram Features
    Figure 5. CT Scan Features
    Figure 6. Kidney Ultrasound Features
    Figure 7. Others Features
    Figure 8. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Application: 2021 VS 2028
    Figure 9. Hospitals Case Studies
    Figure 10. Pharmaceutical Labs Case Studies
    Figure 11. Genomics Laboratories Case Studies
    Figure 12. Others Case Studies
    Figure 13. Kidney Cancer Therapeutics and Diagnostics Report Years Considered
    Figure 14. Global Kidney Cancer Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Kidney Cancer Therapeutics and Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Region: 2021 VS 2028
    Figure 17. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Players in 2021
    Figure 18. Global Top Kidney Cancer Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics and Diagnostics as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Kidney Cancer Therapeutics and Diagnostics Revenue in 2021
    Figure 20. North America Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 22. North America Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 23. North America Kidney Cancer Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 24. United States Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 30. Germany Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size Share by Region (2017-2028)
    Figure 40. China Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 50. Mexico Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 56. Turkey Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Bayer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 60. Hoffmann La Roche Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 62. Novartis Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 63. Pfizer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 64. Abbott Laboratories Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 65. Amgen Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 66. Genentech Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 67. Cerulean Pharma Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 68. Seattle Genetics Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed